首页> 美国卫生研究院文献>Annals of Medicine and Surgery >SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection
【2h】

SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection

机译:SARS-COV-2拉丁美洲的巴西变种:公共卫生和疫苗保护迫切需要更严格的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

COVID-19 has not only created a pandemic but also affected both economically and socially in all countries. It has further created a socio-economic chaos throughout Latin America. Currently, some new SARS-CoV-2 variants are circulating in Latin America and one among the significant variant belongs to the P.1 lineage (B.1.1.28.1) that has 17 mutations. The essential modifications located in the spike glycoprotein RBD include E484K, K417T and N501Y. Along with the P.1 lineage, P.2 lineage (B.1.1.28.2) has also appeared recently. Details on all the variants are unknown, along with the Brazil variants at this time. Therefore, we call for intensive research to collect more data to understand the variants' virulence and the effects on vaccine efficacy.
机译:Covid-19不仅创造了大流行,而且在所有国家的经济和社会上都影响了大流行。它进一步在拉丁美洲创造了一个社会经济混乱。目前,一些新的SARS-COV-2变体在拉丁美洲循环,其中一个重要的变体属于具有17个突变的P.1谱系(B.1.1.28.1)。位于穗糖蛋白RBD中的基本修饰包括E484K,K417T和N501Y。随着P.1谱系,最近也出现了P.2谱系(B.1.1.28.2)。有关所有变体的细节未知,此时与巴西变体一起。因此,我们呼吁密集研究,收集更多数据以了解变体的毒力和对疫苗疗效的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号